Vasilios J. Kalogredis

November 30, 2020 | The Legal Intelligencer

Private equity and other nondoctor investment in U.S. health care has grown significantly over the past decade thanks to investors who have been keen on getting into a large market with potentially high returns.

By Vasilios J. Kalogredis and Rachel E. (Lusk) Klebanoff

7 minute read

November 02, 2020 | The Legal Intelligencer

On June 23, a federal district court upheld the Centers for Medicare and Medicaid Services' (CMS) Hospital Price Transparency Final Rule, which will require hospitals to provide patients with easily accessible information about standard changes for items and services offered by the hospital, including privately negotiated payment rates with insurers.

By Vasilios J. Kalogredis and Rachel E. (Lusk) Klebanoff

7 minute read

October 05, 2020 | The Legal Intelligencer

The hospital, which has several subsidiaries and a physician network, has agreed to pay the federal government $50 million to resolve allegations that it violated the False Claims Act by knowingly submitting claims to Medicare that resulted from violations of the Physician Self-Referral Law and the Anti-Kickback Statute.

By Vasilios J. Kalogredis and Rachel E. (Lusk) Klebanoff

6 minute read

August 31, 2020 | The Legal Intelligencer

On July 17, the U.S. Court of Appeals for the District of Columbia reversed a lower court's decision and held that the Department of Health and Human Services (HHS) has the authority to cut Medicare payments to hospital off-campus facilities to bring them in line with independent physician practices and other outpatient payments.

By Vasilios J. Kalogredis and Rachel E. (Lusk) Klebanoff

6 minute read

August 03, 2020 | The Legal Intelligencer

After nearly a decade of litigation, Novartis Pharmaceuticals Corp. (Novartis) has agreed to pay over $678 million in separate settlements to resolve claims that it systematically violated the federal False Claims Act and the Anti-Kickback Statute.

By Vasilios J. Kalogredis and Rachel E. Lusk Klebanoff

6 minute read

July 06, 2020 | The Legal Intelligencer

Pennsylvania has been working on improving things as to the dispensing and the use of opioids for the treatment of pain for several years. Up until a few years ago, Pennsylvania was only one of a handful of states that did not have a functioning prescription drug monitoring program.

By Vasilios J. Kalogredis

6 minute read

June 01, 2020 | The Legal Intelligencer

As part of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) signed by President Donald Trump March 27, the U.S. Treasury Department and the Internal Revenue Service (IRS) launched the employee retention credit program designed to encourage businesses, including many of our for-profit and nonprofit health care clients.

By Vasilios J. Kalogredis

6 minute read

April 27, 2020 | The Legal Intelligencer

Now that many small businesses have actually received their PPP loan funds, thereby triggering the eight-week coverage period, the fundamental question has become: How much of my loan will be forgiven, and what will I need to do to apply for forgiveness?

By Vasilios J. Kalogredis

6 minute read

April 02, 2020 | The Legal Intelligencer

For doctors in private practice in particular, decisions about malpractice insurance may be among the most important they will make.

By Vasilios J. Kalogredis

6 minute read

February 27, 2020 | The Legal Intelligencer

On Jan. 15, the Office of Inspector General for the U.S. Department of Health and Human Services issued Advisory Opinion No. 20-02 approving an arrangement under which a pharmaceutical manufacturer could provide financial assistance to certain patients receiving the manufacturer's cell therapy drug.

By Vasilios J. Kalogredis

7 minute read